A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease;Infection cutanée aiguë et nécrosante à Mycobacterium marinum chez un patient traité par infliximab pour une maladie de Crohn

Annales de Dermatologie et de Venereologie

Volumn 136, Issue 11, 2009, Pages 806-810

  Guyot, A ^a   Begon, E ^b   Abramowitz, L ^a   Landry, J ^a   Marinho, E ^a   Descamps, V ^a   Crickx, B ^a  

^a BICHAT HOSPITAL   (France)

^b Hôpital Pontoise   (France)

Author keywords

Anti TNF ; Atypical mycobacteria; Infliximab; Mycobacterium marinum

Indexed keywords

BUDESONIDE; C REACTIVE PROTEIN; CLARITHROMYCIN; DOXYCYCLINE; ETHAMBUTOL; INFLIXIMAB; METHOTREXATE; PREDNISONE; RIFAMPICIN;

ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CROHN DISEASE; DISEASE SEVERITY; DRUG EXPOSURE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; SKIN NECROSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; NECROSIS; SKIN DISEASES, BACTERIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70749097151     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2009.09.009     Document Type: Article

References (14)

1. F. Tubach, D. Salmon-Céron, P. Ravaud, X. Mariette for the RATIO study group The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TNFα therapy Joint Bone Spine 72 2005 456 460
2. N. Chopra, A. Kirschenbaum, and D. Widman Mycobacterium marinum tenosynovitis in a patient on etanercept therapy for rheumatoid arthritis J Clin Rheumatol 8 2002 265 268
3. E. Rallis, E. Koumantaki-Mathioudaki, E. Frangoulis, E. Chatziolou, and A. Katsambas Severe sporotrichoid fish tank granuloma following infliximab therapy Am J Clin Dermatol 8 2007 385 388
4. J. Fallon, S. Patchett, C. Gulmann, and G.M. Murphy Mycobacterium marinum infection complicating Crohn's disease treated with infliximab Clin Exp Dermatol 33 2007 43 45
5. P. Del Giudice, C. Roux, V. Blanc-Amrane, O. Brock, L. Euler-Ziegler, and J. Durant Infection cutanée à Mycobacterium marinum au cours d'un traitement par infliximab Ann Dermatol Venereol 135S 2008 A217
6. C. Sorensen, A. Billet, A. Dadban, F. Dhaille, and C. Lok Infection à Mycobacterium marinum chez une patiente traitée par infliximab pour une maladie de Crohn Ann Dermatol Venereol 135S 2008 A219 A220
7. J.R. Danko, W.R. Gilliland, R.S. Miller, and C.F. Decker Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy Scand J Inf Dis 41 2009 252 255
8. A. Aubry, O. Chosidow, E. Caumes, J. Robert, and E. Cambau Sixty-three cases of Mycobacterium marinum infection Arch Intern Med 162 2002 1746 1752
9. D.E. Furst, R. Wallis, M. Broder, and D.O. Beenhouwer Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infections Semin Arthritis Rheum 36 2006 159 167
10. T. Lahey Invasive Mycobacterium marinum infections Emerg Infect Dis 9 2003 1496 1498
11. R.S. Wallis Reconsidering adjuvant immunotherapy for tuberculosis Clin Infect Dis 41 2005 201 208
12. C. Garcia-Vidal, S. Rodriguez-Fernandez, J. Martinez-Lacasa, M. Salavert, R. Vidal, M. Rodriguez, et al. Carballeira Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis Clin Infect Dis 40 2005 756 759
13. S.M. Arend, E.M.S. Leyten, W.P.J. Franken, E.M. Huisman, and J.T. Van Dissel A patient with de novo tuberculosis during anti-tumor necrosis factor-α therapy illustrating diagnostic pitfalls and paradoxical response to treatment Clin Infect Dis 45 2007 1470 1475
14. Afssaps. Recommandations nationales. Prévention et prise en charge des tuberculoses survenant sous anti-TNFα. Disponible sur http://www.agmed.sante.gouv.fr/htm/10/tnf/reco.pdf [consulté le 22 décembre 2008].